{
  "id": 333065,
  "title": "Bank of America is splashing out $250 million a year on weight loss drugs for its staff: ‘We see a great impact on employees,’ CEO says",
  "url": "https://urgent.news/2026/08/07/bank-of-america-is-splashing-out-250-million-a-year-on-weight-loss",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-07T15:06:01.000Z",
  "source": {
    "name": "Fortune",
    "slug": "fortune",
    "url": "https://fortune.com/2026/08/07/bank-of-america-splashing-out-250-million-a-year-on-weight-loss-drugs-for-staff-great-impact-ceo-says/"
  },
  "original_language": "en",
  "account": "Bank of America is investing $250 million annually in weight loss drugs for employees, CEO Brian Moynihan claims the move is improving employee wellbeing. The banking giant, with a $436 billion market value, is part of a $2 billion wellness package aimed at supporting employee health. While staff may need to cover premiums or co-pays, the remainder is covered by Bank of America, effectively covering a quarter of a billion dollars each year. CEO Moynihan acknowledges the long-term benefits may not be fully realized until years after the employees have left the company. He emphasizes the company's commitment to being a top place to work, stating his belief in the investment despite the hefty cost.",
  "summary": "Weight-loss drugs are becoming a popular perk, with almost a third of workers saying they’d even switch jobs for it. Bank of America has them covered.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}